Abedi Gaballu, F., Abbaspour-Ravasjani, S., Mansoori, B., Yekta, R., Hamishehkar, H., Mohammadi, A., . . . Baradaran, B. (2019). Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line. Iran J Pharm Res.
Chicago-стиль цитированияAbedi Gaballu, Fereydoon, et al. "Comparative of In-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line." Iran J Pharm Res 2019.
MLA-цитированиеAbedi Gaballu, Fereydoon, et al. "Comparative of In-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line." Iran J Pharm Res 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.